Department of Clinical Pharmacology, Clinical Hospital Center Rijeka, Rijeka, Croatia.
University of Rijeka, Faculty of Medicine, Rijeka, Croatia.
Euro Surveill. 2024 Nov;29(46). doi: 10.2807/1560-7917.ES.2024.29.46.2400317.
BackgroundAntibiotic resistance poses a considerable public health threat, with data-driven stewardship a main prevention measure. While quantifying antibiotic consumption is a key component of antibiotic stewardship programmes, the choice of denominator for calculating this metric can impact comparative analyses and trend evaluations substantially, influencing targeted stewardship interventions.AimWe aim to evaluate how using hospital sector-specific antibiotic consumption rate denominators at country level impacts country rankings and trends, addressing the limitations of the commonly used 'defined daily doses (DDD) per 1,000 inhabitants per day' metric.MethodsHospital antibiotic consumption data from ESAC-Net and denominator data from Eurostat ('inhabitants,' 'bed-days' and 'discharges') for 2017-2021 were used to calculate hospital antibiotic consumption rates for 24 reporting European Union/ European Economic Area (EU/EEA) countries. Countries were ranked by their consumption rates and trends were analysed to assess the effects of using different denominators.ResultsCountry rankings and 5-year trend analyses varied depending on the denominator used. Antibiotic consumption rates were more similar when using hospital activity-based denominators 'bed-days' and 'discharges' compared with the population-based 'inhabitants' denominator. Differences in country rankings and trends were also seen among rates derived using 'bed-days' and 'discharges'.ConclusionThe study underscores the importance of using hospital activity-based denominators such as 'bed-days' and 'discharges' when evaluating hospital antibiotic consumption. ESAC-Net's historical reliance on only 'DDD per 1,000 inhabitants per day' is challenged, advocating for the use of multiple hospital activity-based denominators. Corresponding hospital activity denominators for ESAC-Net data will more effectively inform national hospital antibiotic stewardship interventions.
背景
抗生素耐药性对公共健康构成了重大威胁,数据驱动的管理是主要的预防措施。虽然量化抗生素的使用量是抗生素管理计划的关键组成部分,但用于计算该指标的分母的选择会对比较分析和趋势评估产生重大影响,从而影响有针对性的管理干预措施。
目的
我们旨在评估在国家层面使用医院特定部门的抗生素使用率作为分母会如何影响国家排名和趋势,从而解决常用的“每千名居民每日定义日剂量(DDD)”指标的局限性。
方法
我们使用了 2017-2021 年 ESAC-Net 的医院抗生素使用数据和 Eurostat 的分母数据(“居民”、“床日”和“出院人数”),计算了 24 个报告的欧盟/欧洲经济区(EU/EEA)国家的医院抗生素使用率。根据消费率对各国进行排名,并分析趋势,以评估使用不同分母的影响。
结果
使用不同的分母会导致国家排名和 5 年趋势分析的结果发生变化。与基于人口的“居民”分母相比,使用基于医院活动的分母“床日”和“出院人数”计算的抗生素使用率更为相似。使用“床日”和“出院人数”得出的比率也存在国家排名和趋势的差异。
结论
本研究强调了在评估医院抗生素使用量时使用基于医院活动的分母(如“床日”和“出院人数”)的重要性。ESAC-Net 之前仅依赖“每千名居民每日 DDD”的做法受到了挑战,提倡使用多种基于医院活动的分母。为 ESAC-Net 数据提供相应的医院活动分母将更有效地为国家医院抗生素管理干预措施提供信息。